1. | | Recruiting | Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Conditions: refractory chronic lymphocytic leukemia; noncontiguous stage II small lymphocytic lymphoma; recurrent small lymphocytic lymphoma; ... |
2. | | Recruiting | Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma |
3. | | Recruiting | Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma |
4. | | Recruiting | Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma |
5. | | No longer recruiting | Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; Waldenstrom's Macroglobulinemia; recurrent grade III follicular large cell lymphoma; ... |
6. | | No longer recruiting | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ... |
7. | | Completed | Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ... |
8. | | No longer recruiting | Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; Waldenstrom's Macroglobulinemia; ... |
9. | | Completed | Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ... |
10. | | Recruiting | Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; ... |
11. | | Recruiting | Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma |
12. | | Recruiting | Combination Chemotherapy and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma |
13. | | Recruiting | Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
14. | | Not yet recruiting | FR901228 in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Acute Myeloid Leukemia Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
15. | | No longer recruiting | Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma Conditions: Lymphoma; Lymphoma, Small Lymphocytic; Lymphoma, Mantle-Cell; Waldenstrom's Macroglobulinemia; Lymphoma, Mucosa-Associated Lymphoid Tissue |
16. | | Recruiting | Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer Conditions: refractory chronic lymphocytic leukemia; recurrent small lymphocytic lymphoma |
17. | | Suspended | Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma Conditions: B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; Waldenstrom's Macroglobulinemia; recurrent small lymphocytic lymphoma |
18. | | Recruiting | FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma Conditions: recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent small lymphocytic lymphoma |
19. | | No longer recruiting | A Safety and Effectiveness Study of Vaccine Therapy in Patients with Indolent Lymphoma Conditions: Lymphoma, Follicular; Lymphoma, Small Lymphocytic |
20. | | No longer recruiting | Reduction of Immunosuppression Plus Interferon alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant Conditions: Lymphoma; Multiple Myeloma |
21. | | Completed | St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Conditions: Lymphoma; Multiple Myeloma; Leukemia; Eye Cancer |
22. | | Recruiting | Biological Therapy in Treating Patients With Lymphoma or Lymphoproliferative Disease Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma |
23. | | Recruiting | Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
24. | | Recruiting | Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma Conditions: Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; Non-Hodgkin's Lymphoma |
25. | | Recruiting | Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Lymphoma Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia |
26. | | Recruiting | Combination Chemotherapy Followed by Donor Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Genetic Disorders Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm |
27. | | Recruiting | Monoclonal Antibody Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma Conditions: adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma |
28. | | Recruiting | Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia |
29. | | Recruiting | Flavopiridol, Fludarabine, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Hairy Cell Leukemia |
30. | | Recruiting | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer Conditions: adult solid tumor; fever, sweats, and hot flashes; hematopoietic and lymphoid cancer; Infection; Neutropenia |
31. | | Recruiting | Epoetin alfa in Treating Cancer-Related Anemia in Patients With Non-Myeloid Cancer Who Are Not Currently Receiving Chemotherapy or Radiation Therapy Conditions: adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm |
32. | | Recruiting | Dose ranging trial for pixantrone in the FND-R variant regimen in indolent non-Hodgkin's lymphoma Conditions: Lymphoma, Low-Grade; Lymphoma, Small Lymphocytic; Lymphoma, Mixed-Cell, Follicular; Lymphoma, Small Cleaved-Cell, Follicular |
33. | | Recruiting | A Pilot Study of Pivanex in Patients with Chronic Lymphocytic Leukemia Conditions: Leukemia, Lymphocytic, Chronic; Lymphoma, Small Lymphocytic |
34. | | Recruiting | Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated with the Epstein Barr Virus Conditions: Cancer; grade I lymphomatoid granulomatosis; grade II lymphomatoid granulomatosis; recurrent grade I lymphomatoid granulomatosis; ... |
35. | | Recruiting | Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Conditions: Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
36. | | Recruiting | Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
37. | | Recruiting | Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia Conditions: Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
38. | | Recruiting | Combining Chemotherapy, Tacrolimus, Mycophenolate Mofetil, and Radiation Therapy with Donor Bone Marrow Transplantation in Treating Patients with Hematologic Cancer Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
39. | | Recruiting | Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
40. | | No longer recruiting | Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer Conditions: Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases |
41. | | Recruiting | Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Conditions: Cancer; Infection |
42. | | No longer recruiting | Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients Conditions: Breast Cancer; Endocrine Cancer; female reproductive cancer; hematopoietic and lymphoid cancer; Neuroblastoma; psychosocial effects and treatment |
43. | | Recruiting | Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplantation for Hematologic Cancer Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
44. | | Recruiting | Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who are Undergoing Donor Stem Cell Transplantation Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
45. | | Suspended | Motexafin Gadolinium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage II, Stage III, or Stage IV Relapsed or Refractory Non-Hodgkin's Lymphoma Conditions: adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma |
46. | | Recruiting | Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
47. | | Recruiting | Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
48. | | Recruiting | XK469 in Treating Patients With Advanced Solid Tumors or Lymphoma Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
49. | | No longer recruiting | Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer Condition: Cancer |
50. | | No longer recruiting | Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |